Thank you to everyone that listened in today, whether you watched the Zoom live, on Facebook or on YouTube. In this week’s show, James Carthew covered the week’s top stories: Chrysalis (0:20) Baring Emerging EMEA Opportunities (3:23) Ecofin US Renewables (7:21) This week’s interview was with Joe Bauernfreund from AVI Japan Opportunity Trust – watch […]
Smithson supporters stock up – money floods into investment trust on back of second year of strong performance. Smithson Investment Trust has published results for the year ended 31 December 2020. It was a year of strong growth for the trust as it generated a return on NAV of 31.4% and a share price return of […]
Biopharma Credit looking healthy – BioPharma Credit has published its annual report for the period ended 31 December 2020. Highlights are: NAV was fairly flat during the period, decreasing by $0.018 from $1.0217 to $1.0037 8.29 cents per share in total dividends during period, comfortably ahead of the target to distribute at least 7 cents per […]
US Solar beats expectations, looks to expand – US Solar Fund has published results for the year ended 31 December 2020. The highlights are: NAV at 31 December 2020 of $194.2m. The NAV increased by US$1.3m from 30 June 2020, due to construction cost savings on the Milford project, strong operating performance, and discount rate reductions […]
In QuotedData’s morning briefing 16 March 2021: Hipgnosis plans to publish additional financial information which will help investors understand the underlying performance of its portfolio of songs. At the moment, purchases of new songs distort the company’s income. We now know that the portfolio of songs held on 31 December 2020 would have produced total revenue […]
